What is the best way to predict IDDM?

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Genes and immunity·2015

Islet autoimmunity in phenotypic type 2 diabetes patients.

Diabetes, obesity & metabolism·2013

Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

Clinical and experimental immunology·2013

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

Clinical and experimental immunology·2011

Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

The Journal of clinical endocrinology and metabolism·2010

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Genes and immunity·2010

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Relationship Between Environmental Statistics and Predictive Gaze Behaviour During a Manual Interception Task: Eye Movements as Active Inference.

Computational brain & behavior·2026

How Do People Process Information from Automated Decision Aids: an Application of Systems Factorial Technology.

Computational brain & behavior·2026

[What form of governance should be adopted for artificial intelligence in healthcare?]

Recenti progressi in medicina·2026

Methods for Assessing Therapeutic Innovation of Drugs: Changes at the Italian Medicine Agency.

Therapeutic innovation & regulatory science·2026

Thinking about the Impact of Artificial Intelligence on U.S. Health Care Costs and Spending Growth.

NEJM catalyst innovations in care delivery·2026

Leveraging artificial intelligence for workload balancing in information technology departments: A qualitative interpretive study.

Work (Reading, Mass.)·2026

Related Experiment Videos

What is the best way to predict IDDM?

Related Concept Videos

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Islet autoimmunity in phenotypic type 2 diabetes patients.

Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Relationship Between Environmental Statistics and Predictive Gaze Behaviour During a Manual Interception Task: Eye Movements as Active Inference.

How Do People Process Information from Automated Decision Aids: an Application of Systems Factorial Technology.

[What form of governance should be adopted for artificial intelligence in healthcare?]

Methods for Assessing Therapeutic Innovation of Drugs: Changes at the Italian Medicine Agency.

Thinking about the Impact of Artificial Intelligence on U.S. Health Care Costs and Spending Growth.

Leveraging artificial intelligence for workload balancing in information technology departments: A qualitative interpretive study.

Related Experiment Videos

What is the best way to predict IDDM?

Related Concept Videos

Related Articles